Afatinib Impurity 46 | CAS 1092365-58-6 - Request Quote
Afatinib Impurity 46
| SZ CAT No: | SZ-A054070 |
| CAS No | 1092365-58-6 |
| Mol.F. | C6H11NO2 |
| Mol.Wt. | 129.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Afatinib Impurity 46 is chemically (Z)-4-(Dimethylamino)but-2-enoic acid. Afatinib Impurity 46 is supplied with detailed characterization data compliant with regulatory guideline. Afatinib Impurity 46 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1092365-58-6
Purchase 1092365-58-6
Order 1092365-58-6
Enquire 1092365-58-6
price of 1092365-58-6
1092365-58-6 Supplier
1092365-58-6 Manufacturer
1092365-58-6 Exporter
buy high quality Afatinib Impurity 46
Purchase Afatinib Impurity 46
Afatinib Impurity 46 suppliers
Afatinib Impurity 46 manufacturers
Afatinib Impurity 46 price
Order Afatinib Impurity 46
Enquire Afatinib Impurity 46
Afatinib Impurity 46 cost
Afatinib Impurity 46 Supplier
Afatinib Impurity 46 Distributor
Afatinib Impurity 46 for Method Validation
Afatinib Reference Standard
Afatinib Impurity 46 for ANDA Filing
Afatinib Impurity 46 for Forced Degradation Studies
Afatinib Impurity 46 Identification Standards
Afatinib Impurity 46 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


